Yun-Ping Zhou

This inventor holds 9 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Metabolex, Inc., Merck Sharp + Dohme Corp., Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun-Ping Zhou. Retrieved from https://idiyas.com/inventor/yun-ping-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 33.3

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 33(Granted Patents)

Location History:

San Ramon, CA (US) (2006 - 2008)
East Bruswick, NJ (US) (2011)
East Brunswick, NJ (US) (2009 - 2012)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

1 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

patents

where one patent can have more than one assignee

Years Active: 2006-2012

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8268779 - Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition (2012-09-18),

2. 7928058 - Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition (2011-04-19),

3. 7879859 - Diagnosis and treatment of type 2 diabetes and other disorders (2011-02-01),

4. RE40624 - Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK) (2009-01-19),

5. 7344844 - Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK) (2008-03-18),

6. 7294698 - Methods and reagents for diagnosis and treatment of diabetes (2007-11-13),

7. 7144985 - Methods and reagents for diagnosis and treatment of diabetes (2006-12-05),

8. 7109021 - Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK) (2006-09-19),

9. 7087394 - Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP (2006-08-08),

Title: The Innovations of Yun-Ping Zhou

Introduction

Yun-Ping Zhou is a prominent inventor based in San Ramon, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for metabolic diseases. With a total of 9 patents to his name, Zhou's work has the potential to impact the lives of many individuals suffering from conditions such as diabetes and obesity.

Latest Patents

One of Yun-Ping Zhou's latest patents involves a pharmaceutical composition comprising oxyntomodulin derivatives. This innovative composition is designed to aid in reducing body weight and can be utilized in the treatment of metabolic diseases. The modified oxyntomodulin derivatives he has developed are particularly noteworthy for their application in addressing obesity and diabetes.

Career Highlights

Throughout his career, Zhou has worked with notable companies in the pharmaceutical industry, including Metabolex, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the field.

Collaborations

Yun-Ping Zhou has collaborated with several professionals in his field, including Jeffrey D Johnson and Kimberly Marlen. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.

Conclusion

Yun-Ping Zhou's contributions to pharmaceutical innovations, particularly in the treatment of metabolic diseases, highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements that can improve health outcomes for many individuals.

Profile summary based on public USPTO records.